


First Investment: 2021
Finding new drugs to treat disease requires understanding the exact changes in gene and protein expression that make patients sick. Relation Therapeutics is using active graph machine learning, a mathematical method adapted from consumer social networking, to study data from individual human cells to find the most promising ways to treat disease, starting with osteoporosis.
News & Insights

Deep Tech Opportunities Report

News
Relation Therapeutics partners with GSK in history-making collaboration to create new treatments for fibrosis and osteoarthritis

Deep Tech Opportunities Report
DCVC DTOR 2024: In the AI race, data will emerge as the critical asset

News
DCVC leads $35 million financing to help UK TechBio leader Relation Therapeutics to seek new treatments for complex diseases
In The Media
Endpoints News
'It's the biology, stupid': Relation and GSK team up on fibrosis, osteoarthritis
Relation
Endpoints News
‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work
Relation
Clarivate
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
Relation
Explore Companies

Newleos Therapeutics
Transforming the treatment of anxiety and other neuropsychiatric disorders

Grove Biopharma
Putting protein-like drugs inside cells to fight cancer and neurodegeneration

Syntax Bio
Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics
Using state-of-the-art machine learning models to create custom-build protein drugs